| Dr Sherry Denise Okun, MD | |
|
830 S Gloster St, Pathology Department, Tupelo, MS 38801-4934 | |
| (662) 377-3000 | |
| Not Available |
| Full Name | Dr Sherry Denise Okun |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | 830 S Gloster St, Tupelo, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386939478 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 24448 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Mississippi Medical Center | Tupelo, MS | Hospital |
| North Mississippi Medical Center-gilmore Amory | Amory, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tupelo Pathology Group, P.a. | 5698808426 | 5 |
News Archive
The influence of medical imaging is constantly growing, diseases are detected earlier and treatments are becoming more effective. Within the last 25 years, cancer mortality rates have decreased by an impressive 25%. Advances in medical imaging have a big part to play in this achievement and we can expect that as technology continues to develop, mortality rates will drop even further.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Abbott, the global health care company, today announced the opening of the Abbott Asia-Pacific Nutrition Research & Development Center at Singapore's Biopolis Research Park. The center is Abbott's largest nutrition R&D facility outside of the U.S., and Singapore's first nutrition R&D site creating science-based nutritional products for infants, children and adults.
Using a new fluorescent biosensor they developed, researchers at Carnegie Mellon University have discovered how a key set of immune cells exchange information during their coordinated assault on invading pathogens.
› Verified 3 days ago
| Entity Name | Tupelo Pathology Group, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831137512 PECOS PAC ID: 5698808426 Enrollment ID: O20100730000701 |
News Archive
The influence of medical imaging is constantly growing, diseases are detected earlier and treatments are becoming more effective. Within the last 25 years, cancer mortality rates have decreased by an impressive 25%. Advances in medical imaging have a big part to play in this achievement and we can expect that as technology continues to develop, mortality rates will drop even further.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Abbott, the global health care company, today announced the opening of the Abbott Asia-Pacific Nutrition Research & Development Center at Singapore's Biopolis Research Park. The center is Abbott's largest nutrition R&D facility outside of the U.S., and Singapore's first nutrition R&D site creating science-based nutritional products for infants, children and adults.
Using a new fluorescent biosensor they developed, researchers at Carnegie Mellon University have discovered how a key set of immune cells exchange information during their coordinated assault on invading pathogens.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sherry Denise Okun, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325 | Dr Sherry Denise Okun, MD 830 S Gloster St, Pathology Department, Tupelo, MS 38801-4934 Ph: (662) 377-3000 |
News Archive
The influence of medical imaging is constantly growing, diseases are detected earlier and treatments are becoming more effective. Within the last 25 years, cancer mortality rates have decreased by an impressive 25%. Advances in medical imaging have a big part to play in this achievement and we can expect that as technology continues to develop, mortality rates will drop even further.
Regulus Therapeutics Inc. announced today that the United States Patent and Trademark Office (USPTO) has allowed claims in U.S. Application Serial No. 11/977,506 covering methods of antagonizing miR-181a to regulate immune response. This patent is owned by Stanford University and licensed exclusively to Regulus. miR-181a has been shown to regulate the response of immune cells, such as T lymphocytes, to specific stimuli and modulation of miR-181a could lead to a novel treatment of inflammatory disease.
Abbott, the global health care company, today announced the opening of the Abbott Asia-Pacific Nutrition Research & Development Center at Singapore's Biopolis Research Park. The center is Abbott's largest nutrition R&D facility outside of the U.S., and Singapore's first nutrition R&D site creating science-based nutritional products for infants, children and adults.
Using a new fluorescent biosensor they developed, researchers at Carnegie Mellon University have discovered how a key set of immune cells exchange information during their coordinated assault on invading pathogens.
› Verified 3 days ago
Dr. Richard Dwight Griswold, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Dr. Frances Jariel Hairston, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Dr. Cohra Colleen Mankey, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Pathology Dept, Tupelo, MS 38801 Phone: 662-620-7102 Fax: 662-620-7106 | |
Dr. Curtis Lynn Collins, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 830 S Gloster St, Pathology Department, Tupelo, MS 38801 Phone: 662-377-3000 | |
Harold Edward Sightler, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Pathology Dept, Tupelo, MS 38801 Phone: 662-620-1468 | |
Lulin Hu, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 830 S Gloster St, Tupelo, MS 38801 Phone: 662-377-3000 Fax: 419-866-5453 | |
Dr. Jerry Pascall Moore, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 146 Road 83, Tupelo, MS 38801 Phone: 662-407-0199 |